Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.52 |
| ▸ | ACP1 | P24666 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | METAP2 | P50579 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.50 |
| ▸ | CDK2 | P24941 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17591077 | 0.86 | MEN1 (0.71) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL592704 | 0.81 | MEN1 (0.65) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL2656574 | 0.80 | MEN1 (0.63) | MEN1KMT2AMAPTPKMHTT | |
| Trifluoroacetic Acid SCHEMBL29366000 | 0.80 | MEN1 (0.58) | MEN1KMT2AMAPTPKMHTT | |
| Trifluoroacetic Acid SCHEMBL29744983 | 0.80 | MEN1 (0.58) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL5945899 | 0.79 | MEN1 (0.57) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL7375 | 0.76 | — | — | |
| SCHEMBL14420964 | 0.76 | MEN1 (0.67) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL28267268 | 0.75 | MEN1 (0.57) | MEN1KMT2AMAPTPKMHTT | |
| SCHEMBL352731 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101652375-B | Electroluminescent metal complex | 巴斯夫欧洲公司 | 2016-08-24 | — | — | CN | disclosed |
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-9284278-B2 | Electroluminescent metal complex | BASF SE (DE) | 2016-03-15 | — | — | US | disclosed |
| US-9284278-B2 | Electroluminescent metal complex | BASF SE (DE) | 2016-03-15 | — | — | US | disclosed |
| EP-2139907-B1 | ELECTROLUMINESCENT METAL COMPLEX | BASF SE (DE) | 2013-08-14 | — | — | EP | disclosed |
| EP-2112994-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | BASF SE (DE) | 2011-01-26 | — | — | EP | disclosed |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | CIBA CORPORATION (US) | 2010-02-25 | — | — | US | disclosed |
| EP-2139907-A1 | ELECTROLUMINESCENT METAL COMPLEX | BASF SE (DE) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008101842-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | BASF SE (CH) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008098851-A1 | ELECTROLUMINESCENT METAL COMPLEX | BASF SE (CH) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008098851-A1 | ELECTROLUMINESCENT METAL COMPLEX | BASF SE (CH) | 2008-08-21 | — | — | WO | disclosed |
| EP-1343561-A1 | SERINE PROTEASE INHIBITORS | Tularik Limited (GB) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002047762-A1 | SERINE PROTEASE INHIBITORS | TULARIK LIMITED (GB) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | OCIAD1, OCIAD2, OXA1L | MEN1 3762/4885KMT2A 2638/4885MAPT 388/4885 |
| US-20100044688-A1 | ELECTROLUMINESCENT METAL COMPLEX | LDHA, LDHB, NRP1 | MEN1 1969/4885KMT2A 3577/4885MAPT 4595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.